期刊
AGING-US
卷 11, 期 9, 页码 2551-2564出版社
IMPACT JOURNALS LLC
DOI: 10.18632/aging.101876
关键词
miR-124; SIRT1; ROS; JNK; cisplatin; HCC
资金
- Provincial basic and applied basic research project (provincial natural fund) Doctor startup project [2016A030310089]
Drug resistance is still a major obstacle for efficient treatment of hepatocellular carcinoma (HCC) during the cisplatin-based chemotherapy. Recent studies have demonstrated that CD133 positive population of cancer cells are responsible for multiple drug resistance. We are supposed to take strategies to sensitize CD133(+) HCC cells to cisplatin treatment. In the present study, CD133(+) HCC cells showed significant cisplatin-resistance compared to the CD133(-) HCC cells. Downregulation of miR-124 was observed in CD133(+) HCC cells. However, enforced expression of miR-124 can increase the sensitivity of CD133(+) HCC cells to cisplatin treatment in vitro and in vivo. Mechanically, overexpression of miR-124 was found to inhibit the expression of SIRT1 and thus promoted the generation of ROS and phosphorylation of JNK. As the results, overexpression of miR-124 expanded the apoptosis in cisplatin-treated CD133(+) HCC cells. We then demonstrated that overexpression of miR-124 sensitized cisplatin-induced cytotoxicity against CD133(+) hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据